Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
NCT ID: NCT00962494
Last Updated: 2013-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
585 participants
INTERVENTIONAL
2009-07-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
NCT05056077
Health and Energy Through Active Living Every Day After Cancer Intervention for Cancer Survivors
NCT05356988
RISE - Reduce Sitting Time Among Breast Cancer Survivors
NCT05260723
Study to Education Childhood Cancer Survivors About Survivorship Care
NCT01742481
Survivors Uniting for Remote Guided Exercise
NCT07290309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each workshop is 6 weeks with new lessons each week. You will be asked to log on at your convenience 2-3 times each week for a total of 1-2 hours, to read the lessons, complete assignments, and share your ideas and experiences with your classmates. There are no requirements that participants log in at the same time.
With the moderators and other workshop participants, you will discuss:
* Healthy eating
* Managing fatigue
* Managing stress
* Starting and maintaining an appropriate physical activity program
* Getting a good night's sleep
* Dealing with difficult emotions
* Solving the problems caused by having had cancer
* Communicating better with your health care professionals
* Communicating better with your friends, family and coworkers
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
online workshop
Cancer: Thriving and Surviving Online Workshop
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cancer: Thriving and Surviving Online Workshop
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hawaii Cancer Research Center
OTHER
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Lorig
Professor of Medicine, Emerita
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kate R Lorig
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Macmillan Cancer Support
London, UK, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bantum EO, Albright CL, White KK, Berenberg JL, Layi G, Ritter PL, Laurent D, Plant K, Lorig K. Surviving and thriving with cancer using a Web-based health behavior change intervention: randomized controlled trial. J Med Internet Res. 2014 Feb 24;16(2):e54. doi: 10.2196/jmir.3020.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-07292009-3460
Identifier Type: OTHER
Identifier Source: secondary_id
VAR0044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.